-
1.
公开(公告)号:US20240075036A1
公开(公告)日:2024-03-07
申请号:US18280370
申请日:2022-03-18
发明人: Florian GRETEN , Mark SCHMITT , Jalaj GUPTA
IPC分类号: A61K31/513 , A61K31/17 , A61K31/198 , A61K31/416 , A61K31/436 , A61K31/4418 , A61K31/522 , A61K31/551 , A61K31/65 , A61K31/675 , A61K31/7076 , A61K31/7084 , A61K38/17 , A61K38/20 , A61K38/45 , A61K45/06 , A61P35/00
CPC分类号: A61K31/513 , A61K31/17 , A61K31/198 , A61K31/416 , A61K31/436 , A61K31/4418 , A61K31/522 , A61K31/551 , A61K31/65 , A61K31/675 , A61K31/7076 , A61K31/7084 , A61K38/1793 , A61K38/2006 , A61K38/45 , A61K45/06 , A61P35/00
摘要: The present invention relates to the use of inhibitors of the P2X4 receptor or inhibitors of the P2X4 receptor signaling pathway in combination with an effective amount of a “cell death inducing chemotherapeutic drug” or “cell death inducing therapy” in the prevention and/or treatment of a solid tumor or metastases thereof in a subject, in particular in colorectal cancer (CRC).